Van Andel Research Institute
27
4
9
15
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
7.4%
2 terminated/withdrawn out of 27 trials
88.2%
+1.7% vs industry average
4%
1 trials in Phase 3/4
20%
3 of 15 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (27)
SMART Diets for MASLD
Role: collaborator
A Trial to Test the Use of Dapansutrile, an Anti-inflammatory Medication, in People With Parkinson's Disease
Role: collaborator
Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed
Role: collaborator
Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer
Role: collaborator
Edmond J. Safra Accelerating Clinical Trials in Parkinson's Disease: A Multiarm Multi-stage Platform Trial
Role: collaborator
Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer.
Role: collaborator
Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach.
Role: collaborator
A Longitudinal Study of Inflammatory Pathways in Depression
Role: lead
Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS
Role: collaborator
13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients.
Role: collaborator
A Trial Using Molecular-Guided Therapy in Patients With Refractory or Recurrent Neuroblastoma
Role: collaborator
Extracorporeal Membrane Oxygenation (ECMO): Blood Cells
Role: collaborator
Pancreatic Cancer Biomarker Study
Role: lead
The Microbiome in Parkinson's Disease
Role: collaborator
Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile
Role: collaborator
Evaluation of Formin Gene Status and Expression in Myeloproliferative and Myelodysplastic Disorders
Role: collaborator
Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer
Role: collaborator
Decitabine and Talazoparib in Untreated AML and R/R AML
Role: collaborator
Atezolizumab + Guadecitabine in Patients With Checkpoint Inhibitor Refractory or Resistant Urothelial Carcinoma
Role: collaborator
Biomarkers as Predictors of Suicidal Risk in Adolescents
Role: collaborator